About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Eurasian Hematology-Oncology Group
http://www.ehog.net/
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Leukemia
Lymphoma
Myeloma
MDS and MPN
Benign Hematology
Videos
8th Eurasian Hematology Oncology Summit
XIth Eurasian Hematology-Oncology Congress - EHOC 2020
Palliative & Supportive Care
COVID-19
Basic Science
Leukemia
Lymphoma
Myeloma
MDS and MPN
Benign Hematology
Lung
Business
7th Eurasian Hematology Oncology Summit
COVID-19
Leukemia
Lymphoma
Myeloma
MDS and MPN
Xth Eurasian Hematology-Oncology Congress
Breast
Lung
Hematologic Oncology
Gastrointestinal
Genitourinary
General Oncology
Sarcoma
Skin
Head & Neck
Events
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
M
Novel Approaches for PV: Can We Achieve CHR and Improve Disease Burden With Ropeginterferon Alfa-2b vs. SoC? Is 2L Ruxolitinib the Best Choice for HU-Resistant Patients?
By
XIth Eurasian Hematology-Oncology Congress - EHOC 2020
FEATURING
Martin Ellis
By
XIth Eurasian Hematology-Oncology Congress - EHOC 2020
FEATURING
Martin Ellis
5 views
January 18, 2021
0 Comments
Login to view comments.
Click here to Login
Featured Video
15:14
Icahn School of Medicine at Mount Sinai
Safety Profile of Ruxolitinib in Patients With MF
Feat.
D. Tremblay
Featured Video
13:04
Winship Cancer Institute - Emory University
Treatment-Related Quality of Life in MF
Feat.
A. Hunter
MDS and MPN
21:56
XIth Eurasian Hematology-Oncology Congress - EHOC 2020
Leukemic Transformations of MPNs: What Mutations Are Associated With…
Feat.
T. Mughal
25:23
XIth Eurasian Hematology-Oncology Congress - EHOC 2020
MDS Essentials: How Common Are Comorbidities? Should Risk Score Dete…
Feat.
M. Çetiner
09:57
XIth Eurasian Hematology-Oncology Congress - EHOC 2020
LR-MDS: Are ESAs Effective in the Treatment of Anemia? Is PLT Transf…
Feat.
M. Mittelman
10:25
XIth Eurasian Hematology-Oncology Congress - EHOC 2020
HR-MDS: Are HMAs the Best Option? Should We Consider Changing the Pa…
Feat.
M. Mittelman
22:45
XIth Eurasian Hematology-Oncology Congress - EHOC 2020
Novel Approaches for PV: Can We Achieve CHR and Improve Disease Burd…
Feat.
M. Ellis
12:47
XIth Eurasian Hematology-Oncology Congress - EHOC 2020
MDS Updates: Can We Achieve Long-Term Transfusion Independence With …
Feat.
G. Garcia-Manero
